Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARK A BARTZ

Allopathic & Osteopathic Physicians Family Medicine

NPI
1447300173
CMS profile
246663
Location
GREENWOOD, SC

General Payments · PY2018–2022

$1,622.53

  • Reported across 133 records
  • CMS publication 2026-01-23

Latest program year · PY2022

$229.33

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2022 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $229.33 15

By paying entity

PY2022 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $79.41 5
DEXCOM, INC. $30.13 2
Lilly USA, LLC $28.42 2
Amgen Inc. $17.65 1
IDORSIA PHARMACEUTICALS US INC $15.34 1
Amarin Pharma Inc. $15.26 1
ABBVIE INC. $15.03 1
GlaxoSmithKline, LLC. $14.29 1
PFIZER INC. $13.80 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $457.48 40
PY2019 $401.69 38
PY2020 $259.16 19
PY2021 $274.87 21
PY2022 $229.33 15

Payment records · PY2022 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2022 2018201920202021 Record-level detail is published for PY2022; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $15.03 07/06/2022 Food and Beverage Undisputed 01/23/2026 890571861 CMS
Amarin Pharma Inc. $15.26 03/31/2022 Food and Beverage Undisputed 01/23/2026 913958337 CMS
Amgen Inc. $17.65 10/26/2022 Food and Beverage Undisputed 01/23/2026 939876961 CMS
Dexcom, Inc. $14.16 07/20/2022 Food and Beverage Undisputed 01/23/2026 957384849 CMS
Dexcom, Inc. $15.97 11/30/2022 Food and Beverage Undisputed 01/23/2026 957384853 CMS
GlaxoSmithKline, LLC. $14.29 11/28/2022 Food and Beverage Undisputed 01/23/2026 944821747 CMS
IDORSIA PHARMACEUTICALS US INC $15.34 11/21/2022 Food and Beverage Undisputed 01/23/2026 942812179 CMS
Lilly USA, LLC $15.13 08/17/2022 Food and Beverage Undisputed 01/23/2026 918151759 CMS
Lilly USA, LLC $13.29 09/28/2022 Food and Beverage Undisputed 01/23/2026 918260801 CMS
Novo Nordisk Inc $17.91 02/21/2022 Food and Beverage Undisputed 01/23/2026 898629055 CMS
Novo Nordisk Inc $15.03 07/11/2022 Food and Beverage Undisputed 01/23/2026 899202525 CMS
Novo Nordisk Inc $15.13 10/05/2022 Food and Beverage Undisputed 01/23/2026 899108961 CMS
Novo Nordisk Inc $13.36 11/07/2022 Food and Beverage Undisputed 01/23/2026 898628919 CMS
Novo Nordisk Inc $17.98 12/05/2022 Food and Beverage Undisputed 01/23/2026 898670763 CMS
PFIZER INC. $13.80 07/27/2022 Food and Beverage Undisputed 01/23/2026 949201139 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022
Generated from
OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.